What an absolute crock. Tillett has said that the end game is to sell the tech to big pharma. Then, why does it matter what the share price is doing now then? Also, the capital raise where shareholders who hadn't sold shares were prioritised over people who had sold (managed their capital) is an absolute scam. Too much time spent by management on forums and social media focusing on the shareprice and “ what is best for our shareholders“.
Ann: Race Oncology Announces On-Market Share Buyback, page-186
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
